Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021

This report describes how survivors of COVID-19 were at higher risk for developing many other health conditions.

The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID

The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID

IJERPH, Free Full-Text

PDF) Association between long COVID symptoms and employment status

Nirmatrelvir/ritonavir and risk of long COVID symptoms: a retrospective cohort study

Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city

Acute and postacute sequelae associated with SARS-CoV-2 reinfection

COVID-19's Impact on the Interdisciplinary Primary Care Workforce

Association of Self-Reported COVID-19 Vaccination Status with COVID-19 Infection among Adult Long-Term Hematopoietic Cell Transplantation Survivors - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation

Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions

CDC Science behind Long COVID

COVID-19 monoclonal antibody treatment impact on symptoms and post

Prevalence and Characteristics of Long COVID 7–12 Months After Hospitalization Among Patients From an Urban Safety-Net Hospital: A Pilot Study - AJPM Focus

Probable COVID-19 infection is associated with subsequent poorer mental health and greater loneliness in the UK COVID-19 Mental Health and Wellbeing study